X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Abbott India with SUVEN LIFE - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs SUVEN LIFE - Comparison Results

ABBOTT INDIA    Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA SUVEN LIFE ABBOTT INDIA/
SUVEN LIFE
 
P/E (TTM) x 43.0 19.5 220.2% View Chart
P/BV x 10.7 3.6 296.4% View Chart
Dividend Yield % 0.6 1.0 60.5%  

Financials

 ABBOTT INDIA   SUVEN LIFE
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-16
SUVEN LIFE
Mar-16
ABBOTT INDIA/
SUVEN LIFE
5-Yr Chart
Click to enlarge
High Rs6,015339 1,777.0%   
Low Rs3,707144 2,567.2%   
Sales per share (Unadj.) Rs1,236.939.2 3,151.7%  
Earnings per share (Unadj.) Rs122.27.5 1,637.5%  
Cash flow per share (Unadj.) Rs129.08.8 1,469.8%  
Dividends per share (Unadj.) Rs35.002.00 1,750.0%  
Dividend yield (eoy) %0.70.8 86.9%  
Book value per share (Unadj.) Rs521.249.0 1,063.8%  
Shares outstanding (eoy) m21.25127.28 16.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.96.2 63.9%   
Avg P/E ratio x39.832.4 123.0%  
P/CF ratio (eoy) x37.727.5 137.0%  
Price / Book Value ratio x9.34.9 189.2%  
Dividend payout %28.626.8 106.9%   
Avg Mkt Cap Rs m103,29630,732 336.1%   
No. of employees `0003.01.0 309.9%   
Total wages/salary Rs m3,370416 809.3%   
Avg. sales/employee Rs Th8,891.85,236.1 169.8%   
Avg. wages/employee Rs Th1,140.0436.5 261.2%   
Avg. net profit/employee Rs Th878.3995.5 88.2%   
INCOME DATA
Net Sales Rs m26,2844,995 526.2%  
Other income Rs m504194 260.7%   
Total revenues Rs m26,7895,189 516.3%   
Gross profit Rs m3,6651,233 297.4%  
Depreciation Rs m144167 86.4%   
Interest Rs m854 14.9%   
Profit before tax Rs m4,0171,205 333.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,421255 557.3%   
Profit after tax Rs m2,596950 273.4%  
Gross profit margin %13.924.7 56.5%  
Effective tax rate %35.421.2 167.1%   
Net profit margin %9.919.0 52.0%  
BALANCE SHEET DATA
Current assets Rs m14,4464,986 289.7%   
Current liabilities Rs m4,7251,042 453.3%   
Net working cap to sales %37.079.0 46.8%  
Current ratio x3.14.8 63.9%  
Inventory Days Days5161 84.3%  
Debtors Days Days2039 50.0%  
Net fixed assets Rs m1,1133,126 35.6%   
Share capital Rs m213127 166.9%   
"Free" reserves Rs m10,8083,717 290.7%   
Net worth Rs m11,0766,236 177.6%   
Long term debt Rs m0432 0.0%   
Total assets Rs m16,2418,079 201.0%  
Interest coverage x497.023.2 2,139.6%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x1.60.6 261.8%   
Return on assets %16.012.4 129.1%  
Return on equity %23.415.2 153.9%  
Return on capital %36.318.9 192.5%  
Exports to sales %0.687.5 0.7%   
Imports to sales %12.612.2 103.4%   
Exports (fob) Rs m1624,371 3.7%   
Imports (cif) Rs m3,322611 543.9%   
Fx inflow Rs m2684,666 5.7%   
Fx outflow Rs m3,927942 416.9%   
Net fx Rs m-3,6593,724 -98.3%   
CASH FLOW
From Operations Rs m2,514922 272.7%  
From Investments Rs m-800-619 129.1%  
From Financial Activity Rs m-803-698 115.0%  
Net Cashflow Rs m912-396 -230.5%  

Share Holding

Indian Promoters % 0.0 63.4 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 7.9 0.0 -  
FIIs % 0.1 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 17.1 36.5 46.8%  
Shareholders   18,270 37,287 49.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   TORRENT PHARMA  ALKEM LABORATORIES  DIVIS LABORATORIES  PFIZER  ALEMBIC PHARMA  

Compare ABBOTT INDIA With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Extend Losses; Capital Goods Sector Down 1.7%(11:30 am)

Indian share markets are presently trading on a negative note. Sectoral indices are trading in the red with stocks in the capital goods sector and metal sector witnessing maximum selling pressure.

Related Views on News

Suven Lifesciences: Profits Decline due to Higher tax outgo in the quarter (Quarterly Results Update - Detailed)

Sep 22, 2017

Muted growth in CRAMS segment continues to impact topline.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

More Views on News

Most Popular

Here's What You Should Do in this Market Crash(The 5 Minute Wrapup)

Feb 6, 2018

The market correction has provided a golden opportunity to buy five high-quality safe stocks.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

When Small is Not Always Beautiful(Chart Of The Day)

Feb 6, 2018

Big companies enjoying tax deductions and exemptions have an edge over the small companies.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Feb 19, 2018 12:01 PM

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA 8-QTR ANALYSIS

COMPARE ABBOTT INDIA WITH

MARKET STATS